Skip to content

A study to test how BI 456906 is taken up in the blood of people with and without kidney problems

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-508557-13-00
Acronym
1404-0009
Enrollment
54
Registered
2024-02-23
Start date
2024-05-08
Completion date
2025-09-23
Last updated
2025-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy, moderate and severe), Renal impairment (mild

Interventions

None listed

Sponsors

Boehringer Ingelheim International GmbH
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Germany

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026